Corvus Pharmaceuticals, Inc. (CRVS) Stock News & Chart | StockAdder

(CRVS)

Corvus Pharmaceuticals, Inc.

Stock chart and latest news for Corvus Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Corvus Pharmaceuticals, Inc. News

PRO

Is Corvus Pharmaceuticals (CRVS) Still Attractive After Its Recent Share Price Surge

Feb 16, 2026 Seeking Alpha

Corvus Pharmaceuticals: Strong Clinical Narrative, Already Priced For Success

Apr 8, 2026 Investing.com

Corvus Pharma stock falls after announcing $150 million offering

Jan 20, 2026 Stock Titan

Corvus Pharmaceuticals (NASDAQ: CRVS) launches $200M at-the-market stock program

Mar 13, 2026 Investor's Business Daily

Why Small Biotech Stock Corvus Pharma Just Launched To A Nine-Year High

Jan 20, 2026 simplywall.st

A Look At Corvus Pharmaceuticals (CRVS) Valuation After Recent Share Price Swings

Mar 15, 2026 TradingView — Track All Markets

What made Corvus stock double on Tuesday and is it sustainable?

Jan 20, 2026 Yahoo Finance

Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why

Jan 27, 2026 Seeking Alpha

Soquelitinib Data Push Corvus Pharmaceuticals Stock Higher: What You Should Know (CRVS)

Jan 21, 2026 Stock Titan

Corvus Pharma raises $175M to advance lymphoma and atopic dermatitis trials

Jan 21, 2026 Investing.com

Mizuho raises Corvus Pharmaceuticals stock price target to $20 on strong trial data

Jan 20, 2026 simplywall.st

Is Corvus Pharmaceuticals (CRVS) Now Attractive After Recent Share Price Volatility?